000143210 001__ 143210
000143210 005__ 20240229112544.0
000143210 0247_ $$2doi$$a10.1158/1078-0432.CCR-18-1965
000143210 0247_ $$2pmid$$apmid:30530705
000143210 0247_ $$2ISSN$$a1078-0432
000143210 0247_ $$2ISSN$$a1557-3265
000143210 0247_ $$2altmetric$$aaltmetric:52361025
000143210 037__ $$aDKFZ-2019-00809
000143210 041__ $$aeng
000143210 082__ $$a610
000143210 1001_ $$0P:(DE-HGF)0$$aBuhl, Juliane L$$b0$$eFirst author
000143210 245__ $$aThe Senescence-associated Secretory Phenotype Mediates Oncogene-induced Senescence in Pediatric Pilocytic Astrocytoma.
000143210 260__ $$aPhiladelphia, Pa. [u.a.]$$bAACR$$c2019
000143210 3367_ $$2DRIVER$$aarticle
000143210 3367_ $$2DataCite$$aOutput Types/Journal article
000143210 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1573808380_29701
000143210 3367_ $$2BibTeX$$aARTICLE
000143210 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000143210 3367_ $$00$$2EndNote$$aJournal Article
000143210 520__ $$aPilocytic astrocytoma is the most common childhood brain tumor, characterized by constitutive MAPK activation. MAPK signaling induces oncogene-induced senescence (OIS), which may cause unpredictable growth behavior of pilocytic astrocytomas. The senescence-associated secretory phenotype (SASP) has been shown to regulate OIS, but its role in pilocytic astrocytoma remains unknown.Experimental Design: The patient-derived pilocytic astrocytoma cell culture model, DKFZ-BT66, was used to demonstrate presence of the SASP and analyze its impact on OIS in pilocytic astrocytoma. The model allows for doxycycline-inducible switching between proliferation and OIS. Both states were studied using gene expression profiling (GEP), Western blot, ELISA, and cell viability testing. Primary pilocytic astrocytoma tumors were analyzed by GEP and multiplex assay.SASP factors were upregulated in primary human and murine pilocytic astrocytoma and during OIS in DKFZ-BT66 cells. Conditioned medium induced growth arrest of proliferating pilocytic astrocytoma cells. The SASP factors IL1B and IL6 were upregulated in primary pilocytic astrocytoma, and both pathways were regulated during OIS in DKFZ-BT66. Stimulation with rIL1B but not rIL6 reduced growth of DKFZ-BT66 cells and induced the SASP. Anti-inflammatory treatment with dexamethasone induced regrowth of senescent cells and inhibited the SASP. Senescent DKFZ-BT66 cells responded to senolytic BCL2 inhibitors. High IL1B and SASP expression in pilocytic astrocytoma tumors was associated with favorable progression-free survival.We provide evidence for the SASP regulating OIS in pediatric pilocytic astrocytoma, with IL1B as a relevant mediator. SASP expression could enable prediction of progression in patients with pilocytic astrocytoma. Further investigation of the SASP driving the unpredictable growth of pilocytic astrocytomas, and its possible therapeutic application, is warranted.
000143210 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000143210 588__ $$aDataset connected to CrossRef, PubMed,
000143210 7001_ $$0P:(DE-He78)a23e88cc676489fe05be8c178ceaf58e$$aSelt, Florian$$b1$$udkfz
000143210 7001_ $$0P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aHielscher, Thomas$$b2$$udkfz
000143210 7001_ $$aGuiho, Romain$$b3
000143210 7001_ $$0P:(DE-He78)3de637452ba900e2bdd359b8f41953bf$$aEcker, Jonas$$b4$$udkfz
000143210 7001_ $$0P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aSahm, Felix$$b5$$udkfz
000143210 7001_ $$0P:(DE-He78)53112ef656923758316e7079710bc988$$aRidinger, Johannes$$b6$$udkfz
000143210 7001_ $$0P:(DE-He78)567e98aaf50a1f3be9ef2f365dda213d$$aRiehl, Dennis$$b7$$udkfz
000143210 7001_ $$0P:(DE-He78)7d5cd95cbedad26188a1df9eeca335ef$$aUsta, Diren$$b8$$udkfz
000143210 7001_ $$0P:(DE-He78)36d3a335ebf4b1d5e1fac7003b2ff440$$aIsmer, Britta$$b9$$udkfz
000143210 7001_ $$0P:(DE-HGF)0$$aSommerkamp, Alexander C$$b10
000143210 7001_ $$aMartinez-Barbera, J. P.$$b11
000143210 7001_ $$0P:(DE-HGF)0$$aWefers, Annika K$$b12
000143210 7001_ $$0P:(DE-He78)a244aa021112b9002419791434bbc71c$$aRemke, Marc$$b13$$udkfz
000143210 7001_ $$0P:(DE-He78)2d0b899984e41ffa8cb15d799d32afd1$$aPicard, Daniel$$b14$$udkfz
000143210 7001_ $$0P:(DE-He78)f2efee17b6ca2f790176a2c036912536$$aPusch, Stefan$$b15$$udkfz
000143210 7001_ $$0P:(DE-He78)bb186a8b38fef24ebd6f11918ade985d$$aGronych, Jan$$b16$$udkfz
000143210 7001_ $$0P:(DE-He78)908367a659dea9e28dac34592b3c46e5$$aOehme, Ina$$b17$$udkfz
000143210 7001_ $$0P:(DE-HGF)0$$avan Tilburg, Cornelis M$$b18
000143210 7001_ $$0P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aKool, Marcel$$b19$$udkfz
000143210 7001_ $$0P:(DE-He78)3b46255435ba2ba48f77f8902bd66f8f$$aKuhn, Daniela$$b20$$udkfz
000143210 7001_ $$0P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aCapper, David$$b21$$udkfz
000143210 7001_ $$0P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$avon Deimling, Andreas$$b22$$udkfz
000143210 7001_ $$aSchuhmann, Martin U$$b23
000143210 7001_ $$aHerold-Mende, Christel$$b24
000143210 7001_ $$0P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aKorshunov, Andrey$$b25$$udkfz
000143210 7001_ $$0P:(DE-HGF)0$$aBrummer, Tilman$$b26
000143210 7001_ $$0P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aPfister, Stefan$$b27$$udkfz
000143210 7001_ $$0P:(DE-He78)551bb92841f634070997aa168d818492$$aJones, David$$b28$$udkfz
000143210 7001_ $$0P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aWitt, Olaf$$b29$$udkfz
000143210 7001_ $$0P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f$$aMilde, Till$$b30$$eLast author$$udkfz
000143210 773__ $$0PERI:(DE-600)2036787-9$$a10.1158/1078-0432.CCR-18-1965$$gVol. 25, no. 6, p. 1851 - 1866$$n6$$p1851 - 1866$$tClinical cancer research$$v25$$x1557-3265$$y2019
000143210 909CO $$ooai:inrepo02.dkfz.de:143210$$pVDB
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a23e88cc676489fe05be8c178ceaf58e$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3de637452ba900e2bdd359b8f41953bf$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a1f4b408b9155beb2a8f7cba4d04fe88$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)53112ef656923758316e7079710bc988$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)567e98aaf50a1f3be9ef2f365dda213d$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7d5cd95cbedad26188a1df9eeca335ef$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)36d3a335ebf4b1d5e1fac7003b2ff440$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b12$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a244aa021112b9002419791434bbc71c$$aDeutsches Krebsforschungszentrum$$b13$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2d0b899984e41ffa8cb15d799d32afd1$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f2efee17b6ca2f790176a2c036912536$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bb186a8b38fef24ebd6f11918ade985d$$aDeutsches Krebsforschungszentrum$$b16$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)908367a659dea9e28dac34592b3c46e5$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b18$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4c28e2aade5f44d8eca9dd8e97638ec8$$aDeutsches Krebsforschungszentrum$$b19$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3b46255435ba2ba48f77f8902bd66f8f$$aDeutsches Krebsforschungszentrum$$b20$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)51bf9ae9cb5771b30c483e5597ef606c$$aDeutsches Krebsforschungszentrum$$b21$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a8a10626a848d31e70cfd96a133cc144$$aDeutsches Krebsforschungszentrum$$b22$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8d9c904a6cea14d4c99c78ba46e41f93$$aDeutsches Krebsforschungszentrum$$b25$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b26$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f746aa965c4e1af518b016de3aaff5d9$$aDeutsches Krebsforschungszentrum$$b27$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)551bb92841f634070997aa168d818492$$aDeutsches Krebsforschungszentrum$$b28$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)143af26de9d57bf624771616318aaf7c$$aDeutsches Krebsforschungszentrum$$b29$$kDKFZ
000143210 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0be2f86573954f87e97f8a4dbb05cb0f$$aDeutsches Krebsforschungszentrum$$b30$$kDKFZ
000143210 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000143210 9141_ $$y2019
000143210 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCLIN CANCER RES : 2017
000143210 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000143210 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000143210 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000143210 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000143210 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000143210 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000143210 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000143210 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000143210 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000143210 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bCLIN CANCER RES : 2017
000143210 9201_ $$0I:(DE-He78)B310-20160331$$kB310$$lKKE Pädiatrische Onkologie$$x0
000143210 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lBiostatistik$$x1
000143210 9201_ $$0I:(DE-He78)B300-20160331$$kB300$$lKKE Neuropathologie$$x2
000143210 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lPädiatrische Neuroonkologie$$x3
000143210 9201_ $$0I:(DE-He78)L401-20160331$$kL401$$lDKTK Essen$$x4
000143210 9201_ $$0I:(DE-He78)B060-20160331$$kB060$$lMolekulare Genetik$$x5
000143210 9201_ $$0I:(DE-He78)B360-20160331$$kB360$$lPediatric Glioma$$x6
000143210 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x7
000143210 9201_ $$0I:(DE-He78)L601-20160331$$kL601$$lDKTK Freiburg$$x8
000143210 9201_ $$0I:(DE-He78)L201-20160331$$kL201$$lDKTK Berlin$$x9
000143210 980__ $$ajournal
000143210 980__ $$aVDB
000143210 980__ $$aI:(DE-He78)B310-20160331
000143210 980__ $$aI:(DE-He78)C060-20160331
000143210 980__ $$aI:(DE-He78)B300-20160331
000143210 980__ $$aI:(DE-He78)B062-20160331
000143210 980__ $$aI:(DE-He78)L401-20160331
000143210 980__ $$aI:(DE-He78)B060-20160331
000143210 980__ $$aI:(DE-He78)B360-20160331
000143210 980__ $$aI:(DE-He78)L101-20160331
000143210 980__ $$aI:(DE-He78)L601-20160331
000143210 980__ $$aI:(DE-He78)L201-20160331
000143210 980__ $$aUNRESTRICTED